In recent studies, the expression of VEGF/VEGFR in acute myeloid leukemia (AML) patients has been detected and the increased levels of plasma VEGF have been correlated with reduced survival and lower remission rates [16, 17]. The gene discussed is KDR; the disease is acute myeloid leukemia.